These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 21554161

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of SCF-engineered particle-based lactose blends in passive dry powder inhalers.
    Schiavone H, Palakodaty S, Clark A, York P, Tzannis ST.
    Int J Pharm; 2004 Aug 20; 281(1-2):55-66. PubMed ID: 15288343
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effects of carrier size and morphology on the dispersion of salbutamol sulphate after aerosolization at different flow rates.
    Zeng XM, Martin GP, Marriott C, Pritchard J.
    J Pharm Pharmacol; 2000 Oct 20; 52(10):1211-21. PubMed ID: 11092565
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of Granulated Lactose as a Carrier for Dry Powder Inhaler Formulations 2: Effect of Drugs and Drug Loading.
    Du P, Du J, Smyth HDC.
    J Pharm Sci; 2017 Jan 20; 106(1):366-376. PubMed ID: 27939234
    [Abstract] [Full Text] [Related]

  • 13. Effect of milling and sieving on functionality of dry powder inhalation products.
    Steckel H, Markefka P, teWierik H, Kammelar R.
    Int J Pharm; 2006 Feb 17; 309(1-2):51-9. PubMed ID: 16377105
    [Abstract] [Full Text] [Related]

  • 14. Effects of surface processing of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate.
    Iida K, Inagaki Y, Todo H, Okamoto H, Danjo K, Luenberger H.
    Chem Pharm Bull (Tokyo); 2004 Aug 17; 52(8):938-42. PubMed ID: 15304985
    [Abstract] [Full Text] [Related]

  • 15. Influence of humidity on the electrostatic charge and aerosol performance of dry powder inhaler carrier based systems.
    Young PM, Sung A, Traini D, Kwok P, Chiou H, Chan HK.
    Pharm Res; 2007 May 17; 24(5):963-70. PubMed ID: 17377746
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Aerosol tribocharging and its relation to the deposition of Oxis™ Turbuhaler® in the electrical next generation impactor.
    Hoe S, Young PM, Traini D.
    J Pharm Sci; 2011 Dec 17; 100(12):5270-80. PubMed ID: 21850666
    [Abstract] [Full Text] [Related]

  • 18. Electrostatic characterisation of inhaled powders: effect of contact surface and relative humidity.
    Elajnaf A, Carter P, Rowley G.
    Eur J Pharm Sci; 2006 Dec 17; 29(5):375-84. PubMed ID: 16952450
    [Abstract] [Full Text] [Related]

  • 19. Particle engineering using sonocrystallization: salbutamol sulphate for pulmonary delivery.
    Dhumal RS, Biradar SV, Paradkar AR, York P.
    Int J Pharm; 2009 Feb 23; 368(1-2):129-37. PubMed ID: 18996462
    [Abstract] [Full Text] [Related]

  • 20. Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate.
    Kaialy W, Ticehurst M, Nokhodchi A.
    Int J Pharm; 2012 Feb 28; 423(2):184-94. PubMed ID: 22197772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.